These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 12508917)

  • 1. The nutritional status has no major role in the age-related reduction of IGF-I secretion.
    Baffoni C; Benso A; Broglio F; Tassone F; Bellone S; Corneli G; Rovere S; Origlia C; Aimaretti G
    J Endocrinol Invest; 2002; 25(10 Suppl):53-4. PubMed ID: 12508917
    [No Abstract]   [Full Text] [Related]  

  • 2. Activity of GH/IGF-I axis in patients with dilated cardiomyopathy.
    Benso A; Broglio F; Gottero C; Di Vito L; Arvat E; Bobbio M; Ghigo E
    J Endocrinol Invest; 1999; 22(10 Suppl):63. PubMed ID: 10727049
    [No Abstract]   [Full Text] [Related]  

  • 3. Correlation between the components of the insulin-like growth factor I system, nutritional status and visceral leishmaniasis.
    Gomes CM; Giannella-Neto D; Gama ME; Pereira JC; Campos MB; Corbett CE
    Trans R Soc Trop Med Hyg; 2007 Jul; 101(7):660-7. PubMed ID: 17442352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum IGF-1, IGFBP-3 and growth hormone levels in children with congenital heart disease: relationship with nutritional status, cyanosis and left ventricular functions.
    Dinleyici EC; Kilic Z; Buyukkaragoz B; Ucar B; Alatas O; Aydogdu SD; Dogruel N
    Neuro Endocrinol Lett; 2007 Jun; 28(3):279-83. PubMed ID: 17627262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic variation in the growth hormone synthesis pathway in relation to circulating insulin-like growth factor-I, insulin-like growth factor binding protein-3, and breast cancer risk: results from the European prospective investigation into cancer and nutrition study.
    Canzian F; McKay JD; Cleveland RJ; Dossus L; Biessy C; Boillot C; Rinaldi S; Llewellyn M; Chajès V; Clavel-Chapelon F; Téhard B; Chang-Claude J; Linseisen J; Lahmann PH; Pischon T; Trichopoulos D; Trichopoulou A; Zilis D; Palli D; Tumino R; Vineis P; Berrino F; Bueno-de-Mesquita HB; van Gils CH; Peeters PH; Pera G; Barricarte A; Chirlaque MD; Quirós JR; Larrañaga N; Martínez-García C; Allen NE; Key TJ; Bingham SA; Khaw KT; Slimani N; Norat T; Riboli E; Kaaks R
    Cancer Epidemiol Biomarkers Prev; 2005 Oct; 14(10):2316-25. PubMed ID: 16214911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neuroregulation of GH secretion in aging].
    Arvat E; Gianotti L; Goffi S; Maccario M; Bellone J; Procopio M; Camanni F; Ghigo E
    Minerva Endocrinol; 1993 Sep; 18(3 Suppl 1):14-20. PubMed ID: 7910654
    [No Abstract]   [Full Text] [Related]  

  • 7. The chronic oral administration of arginine aspartate decreases secretion of IGF-1 and IGFBP-3 in healthy volunteers.
    Blazejewski S; Georges A; Forest K; Corcuff JB; Abouelfath A; Girodet PO; Kamagate M; Jacquet A; Pillet O; Bordenave L; Moore N
    Fundam Clin Pharmacol; 2009 Jun; 23(3):339-44. PubMed ID: 19527301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nutritional predictors of insulin-like growth factor I and their relationships to cancer in men.
    Giovannucci E; Pollak M; Liu Y; Platz EA; Majeed N; Rimm EB; Willett WC
    Cancer Epidemiol Biomarkers Prev; 2003 Feb; 12(2):84-9. PubMed ID: 12582016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multidimensional reference regions for IGF-I, IGFBP-2 and IGFBP-3 concentrations in serum of healthy adults.
    Mattsson A; Svensson D; Schuett B; Osterziel KJ; Ranke MB
    Growth Horm IGF Res; 2008 Dec; 18(6):506-16. PubMed ID: 18550406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IGF-I levels in obesity: their relationship to blood pressure levels.
    Dall'Aglio E; Maggio M; Benedetti N; Caporotundo S; Salimbeni I; Banchini A; Strata A; Valenti G; Ceda GP
    J Endocrinol Invest; 1999; 22(10 Suppl):49-50. PubMed ID: 10727042
    [No Abstract]   [Full Text] [Related]  

  • 11. Hormone replacement for disabilities and diseases of aging.
    Dwivedi RN
    J Indian Med Assoc; 1998 May; 96(5):139-40. PubMed ID: 9828566
    [No Abstract]   [Full Text] [Related]  

  • 12. Associations of insulin-like growth factors, insulin-like growth factor binding proteins and acid-labile subunit with coronary heart disease.
    Fischer F; Schulte H; Mohan S; Tataru MC; Köhler E; Assmann G; von Eckardstein A
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):595-602. PubMed ID: 15521962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors associated with circulating levels of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in 740 women at risk for breast cancer.
    Johansson H; Baglietto L; Guerrieri-Gonzaga A; Bonanni B; Mariette F; Macis D; Serrano D; Sandri MT; Decensi A
    Breast Cancer Res Treat; 2004 Nov; 88(1):63-73. PubMed ID: 15538047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pregnancy-induced changes in insulin-like growth factor I (IGF-I), insulin-like growth factor binding protein 3 (IGFBP-3), and acid-labile subunit (ALS) in patients with growth hormone (GH) deficiency and excess.
    Wiesli P; Zwimpfer C; Zapf J; Schmid C
    Acta Obstet Gynecol Scand; 2006; 85(8):900-5. PubMed ID: 16862465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Are age and educational level the determinants of hormonal parameters considered as indices of andropause?].
    Jankowska EA; Szklarska A; Lopuszańska M; Medraś M
    Pol Merkur Lekarski; 2004 Apr; 16(94):323-7. PubMed ID: 15517925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of insulin-like growth factor I and insulin-like growth factor-binding protein-3 with intelligence quotient among 8- to 9-year-old children in the Avon Longitudinal Study of Parents and Children.
    Gunnell D; Miller LL; Rogers I; Holly JM;
    Pediatrics; 2005 Nov; 116(5):e681-6. PubMed ID: 16263982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reference ranges of serum IGF-1 and IGFBP-3 levels in a general adult population: results of the Study of Health in Pomerania (SHIP).
    Friedrich N; Alte D; Völzke H; Spilcke-Liss E; Lüdemann J; Lerch MM; Kohlmann T; Nauck M; Wallaschofski H
    Growth Horm IGF Res; 2008 Jun; 18(3):228-37. PubMed ID: 17997337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are insulin-like growth factor and its binding proteins 1 and 3 clinically useful as markers of malnutrition, sarcopenia and inflammation in end-stage renal disease?
    Axelsson J; Qureshi AR; Divino-Filho JC; Bárány P; Heimbürger O; Lindholm B; Stenvinkel P
    Eur J Clin Nutr; 2006 Jun; 60(6):718-26. PubMed ID: 16391585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antagonists of growth hormone-releasing hormone inhibit the proliferation of experimental non-small cell lung carcinoma.
    Szereday Z; Schally AV; Varga JL; Kanashiro CA; Hebert F; Armatis P; Groot K; Szepeshazi K; Halmos G; Busto R
    Cancer Res; 2003 Nov; 63(22):7913-9. PubMed ID: 14633721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cranially irradiated adult cancer survivors may have normal spontaneous GH secretion in the presence of discordant peak GH responses to stimulation tests (compensated GH deficiency).
    Darzy KH; Thorner MO; Shalet SM
    Clin Endocrinol (Oxf); 2009 Feb; 70(2):287-93. PubMed ID: 18673465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.